Moderna seeks full FDA approval of its COVID-19 vaccine

More than 124 million doses have been administered under an emergency use authorization.

Sean Keane Former Senior Writer
Sean knows far too much about Marvel, DC and Star Wars, and poured this knowledge into recaps and explainers on CNET. He also worked on breaking news, with a passion for tech, video game and culture.
Expertise Culture | Video Games | Breaking News
Sean Keane

Moderna submitted its coronavirus vaccine for full FDA approval.

Sarah Tew/CNET

Moderna is seeking full approval from the US Food and Drug Administration to administer its coronavirus vaccine in people 18 and older, the company said Monday. The vaccine is being given to adults in America under an emergency use authorization, which was granted in December.

Last week, the pharmaceuticals company said its vaccine is effective in 12- to 17-year-olds, and it will seek approval to administer its vaccine to teenagers this month.

More than 124 million doses of Moderna's vaccine had been administered in the US as of Monday, according to data from the Centers for Disease Control and Prevention. Rival vaccine maker Pfizer sought full approval last month, and more than 159 million doses of its vaccine have been given.

See also: 16 important do's and don'ts for getting your COVID-19 vaccine

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.